Sep 23, 2026 06:02AM
Sep 10, 2026 05:00PM
Sep 10, 2026 12:46PM
Aug 26, 2026 02:11AM
Jul 15, 2026 07:39AM
Jul 14, 2026 07:28AM
Apr 28, 2026 07:27AM Cardiol Therapeutics expands MAVERIC trial network, enrollment reaches 75%
Apr 14, 2026 07:29AM
Apr 14, 2026 07:27AM
Apr 1, 2026 07:33AM
Apr 1, 2026 07:27AM
Feb 25, 2026 07:27AM
Feb 10, 2026 07:29AM
Feb 10, 2026 07:27AM Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure
Jan 23, 2026 09:16AM
Jan 16, 2026 08:48AM
Jan 16, 2026 08:46AM
Jan 16, 2026 08:43AM
Jan 16, 2026 08:42AM
Jan 13, 2026 07:29AM
Jan 13, 2026 07:27AM Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
Dec 2, 2025 06:43AM
Dec 1, 2025 07:29AM
Dec 1, 2025 07:27AM
Nov 13, 2025 07:48AM
Nov 13, 2025 07:45AM
Nov 5, 2025 07:45AM
Oct 21, 2025 07:27AM Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027
Oct 17, 2025 04:36PM
Oct 17, 2025 04:34PM
Sep 17, 2025 03:33PM
Aug 11, 2025 07:27AM
Aug 6, 2025 07:27AM
Jul 23, 2025 06:41AM
Jul 22, 2025 07:30AM Cardiol locks database for phase II myocarditis trial
Jul 22, 2025 07:27AM
Jun 2, 2025 06:36AM
May 29, 2025 07:27AM
May 27, 2025 07:27AM
Apr 29, 2025 07:29AM
Apr 29, 2025 07:27AM
Apr 16, 2025 07:29AM Cardiol Therapeutics (CRDL) Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
Apr 16, 2025 07:27AM
Apr 8, 2025 06:45AM
Apr 1, 2025 07:29AM
Apr 1, 2025 07:27AM
Mar 3, 2025 07:27AM
Feb 20, 2025 07:29AM
Feb 20, 2025 07:27AM Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Dr
Feb 4, 2025 07:27AM

466,314 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All